St. James Investment Company’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-10,288
Closed -$761K 51
2016
Q2
$761K Buy
10,288
+1,489
+17% +$103K 0.1% 40
2016
Q1
$571K Buy
8,799
+681
+8% +$46.3K 0.07% 43
2015
Q4
$626K Buy
8,118
+413
+5% +$32.8K 0.08% 37
2015
Q3
$635K Buy
7,705
+1,401
+22% +$125K 0.08% 37
2015
Q2
$556K Buy
6,304
+809
+15% +$74.2K 0.06% 35
2015
Q1
$486K Buy
5,495
+720
+15% +$63.9K 0.05% 49
2014
Q4
$396K Sell
4,775
-1,552
-25% -$129K 0.04% 35
2014
Q3
$534K Sell
6,327
-311,875
-98% -$25.2M 0.06% 29
2014
Q2
$25.8M Sell
318,202
-366,418
-54% -$28.8M 2.89% 18
2014
Q1
$52.2M Sell
684,620
-35,236
-5% -$2.57M 5.69% 10
2013
Q4
$51.8M Sell
719,856
-4,820
-0.7% -$335K 5.72% 7
2013
Q3
$49.8M Buy
724,676
+3,338
+0.5% +$221K 5.6% 6
2013
Q2
$45.7M Buy
+721,338
New +$46.9M 5.06% 9

Other funds holding NVS

St. James Investment Company's NVS Position: Q3 2016 in Review

St. James Investment Company sold out of Novartis (NVS) in Q3 2016, closing a stake of 10,288 shares — an estimated $761K sold.

St. James Investment Company first reported a position in NVS in Q2 2013 and held it in 13 quarters. The position peaked at $52.2M in Q1 2014. 878 funds tracked by Wall St. Rank hold NVS as of Q3 2016.

  • St. James Investment Company reported no remaining Novartis position as of Q3 2016 after selling out during the quarter.
  • St. James Investment Company sold 10,288 Novartis shares in Q3 2016, an estimated $761K.
  • St. James Investment Company first reported a position in Novartis in Q2 2013 and held it in 13 quarters.
  • St. James Investment Company's Novartis position peaked at $52.2M in Q1 2014.
  • 878 funds tracked by Wall St. Rank held Novartis as of Q3 2016.

Based on St. James Investment Company's 13F filing for Q3 2016, filed 1 Nov 2016.